Use this MDR hub as a root overview for medical devices placed on the EU market. Start with intended purpose and product boundary, confirm whether the product is a medical device, accessory or Annex XVI product without an intended medical purpose, then connect classification, conformity assessment, technical documentation, clinical evaluation, UDI, EUDAMED, PMS, vigilance and legacy-transition evidence to the same device file.
Regulation (EU) 2017/745 replaced the active implantable and medical device directives with one MDR framework for devices other than in vitro diagnostic medical devices. The practical path is evidence-led: document the intended purpose, justify the Annex VIII risk class, identify whether notified body involvement is required, maintain Annex II and III technical documentation, support the clinical evaluation under Article 61 and Annex XIV, and keep post-market surveillance, vigilance, UDI and EUDAMED records current through the device lifecycle.
Run the MDR applicability testTrack MDR application, Article 120 legacy-device conditions, notified body application and agreement evidence, technical documentation updates, clinical evaluation and PMCF outputs, PMS/vigilance records, UDI assignment, EUDAMED actor and device registration, certificate status, and market-surveillance correspondence for each device family.
Deep dive pages for implementation planning, controls, reporting, and evidence.
Use this hub to route MDR work by device family, intended purpose, risk class, economic-operator role, notified body status, clinical evidence route and EU market path. The output should be a controlled device file, not a one-time checklist.
